Envafolimab Combined With Chemotherapy in Neoadjuvant and Conversion Therapy for Head and Neck Squamous Cell Carcinoma

Clinical trial NCT06218004 · UNKNOWN

Trial details

NCT number: NCT06218004
Sponsor: Hairong Liu
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Efficacy and Safety

Start date: 2024-01-25
Primary completion: 2025-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.